
iDose® TR – Sustained-Release Glaucoma Treatment
A next-generation treatment designed to continuously deliver glaucoma medication directly within the eye.
What Is iDose TR?
iDose TR is an innovative, sustained-release drug delivery implant used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Unlike traditional eye drops that require daily use, iDose TR continuously releases a measured dose of medication directly into the eye for months at a time, helping maintain stable eye pressure and reducing the burden of daily drops.How Does iDose TR Work?
The iDose TR implant is a tiny titanium device, smaller than a grain of rice, that is surgically inserted into the eye during a quick, minimally invasive procedure. Once in place, it slowly releases a well-known glaucoma medication (travoprost) into the front part of the eye. This controlled release provides long-term pressure reduction and helps protect the optic nerve from further damage.Benefits of iDose TR
- Long-term IOP control without daily drops
- Reduces fluctuations in eye pressure
- Eliminates issues related to missed doses or improper drop use
- Minimally invasive and performed in-office or outpatient setting
- Sustained delivery for months, with the possibility of future replacement as needed